1. Almeida JI, Javier JJ, Mackay EG, Bautista C, Cher DJ, Proebstle TM. 2017; Thirty-sixth-month follow-up of first-in-human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. J Vasc Surg Venous Lymphat Disord. 5:658–66. DOI:
10.1016/j.jvsv.2017.03.016. PMID:
28818217.
Article
2. Navarro-Triviño FJ, Cuenca-Manteca J, Ruiz-Villaverde R. 2020; Allergic contact dermatitis with systemic symptoms caused by VenaSeal. Contact Dermatitis. 82:185–7. DOI:
10.1111/cod.13431. PMID:
31674037.
Article
3. Lurie F, Creton D, Eklof B, Kabnick LS, Kistner RL, Pichot O, et al. 2005; Prospective randomised study of endovenous radiofrequency obliteration (closure) versus ligation and vein stripping (EVOLVeS): two-year follow-up. Eur J Vasc Endovasc Surg. 29:67–73. DOI:
10.1016/j.ejvs.2004.09.019. PMID:
15570274.
Article
4. Darwood RJ, Theivacumar N, Dellagrammaticas D, Mavor AI, Gough MJ. 2008; Randomized clinical trial comparing endovenous laser ablation with surgery for the treatment of primary great saphenous varicose veins. Br J Surg. 95:294–301. DOI:
10.1002/bjs.6101. PMID:
18278775.
Article
5. Almeida JI, Javier JJ, Mackay E, Bautista C, Proebstle TM. 2013; First human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. J Vasc Surg Venous Lymphat Disord. 1:174–80. DOI:
10.1016/j.jvsv.2012.09.010. PMID:
26992340.
Article
6. Morrison N, Gibson K, Vasquez M, Weiss R, Jones A. 2020; Five-year extension study of patients from a randomized clinical trial (VeClose) comparing cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord. 8:978–89. DOI:
10.1016/j.jvsv.2019.12.080. PMID:
32205125.
Article
7. Jones AD, Boyle EM, Woltjer R, Jundt JP, Williams AN. 2019; Persistent type IV hypersensitivity after cyanoacrylate closure of the great saphenous vein. J Vasc Surg Cases Innov Tech. 5:372–4. DOI:
10.1016/j.jvscit.2019.05.004. PMID:
31440717. PMCID:
PMC6699189.
Article
8. Dimech AP, Cassar K. 2020; Efficacy of cyanoacrylate glue ablation of primary truncal varicose veins compared to existingendovenous techniques: a systematic review of the literature. Surg J (N Y). 6:e77–86. DOI:
10.1055/s-0040-1708866. PMID:
32577526. PMCID:
PMC7305022.
9. Cho S, Gibson K, Lee SH, Kim SY, Joh JH. 2020; Incidence, classification, and risk factors of endovenousglue-induced thrombosis after cyanoacrylate closure of the incompetent saphenous vein. J Vasc Surg Venous Lymphat Disord. 8:991–8. DOI:
10.1016/j.jvsv.2020.01.009. PMID:
32179036.
10. Proebstle TM, Alm J, Dimitri S, Rasmussen L, Whiteley M, Lawson J, et al. 2015; The European multicenter cohort study on cyanoacrylate embolization of refluxing great saphenous veins. J Vasc Surg Venous Lymphat Disord. 3:2–7. DOI:
10.1016/j.jvsv.2014.09.001. PMID:
26993674.
Article
11. Morrison N, Gibson K, McEnroe S, Goldman M, King T, Weiss R, et al. 2015; Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vasc Surg. 61:985–94. DOI:
10.1016/j.jvs.2014.11.071. PMID:
25650040.
Article
13. Korkmaz Ö, Göksel S, Gül M, Başçil H, Yildir Y, Berkan Ö. 2018; Does the use of N-butyl-2 cyanoacrylate in the treatment of lower extremity superficial varicose veins cause acute systemic inflammation and allergic reactions? Cardiovasc J Afr. 29:213–7. DOI:
10.5830/CVJA-2018-012. PMID:
30204219.
Article
15. Park I, Jeong MH, Park CJ, Park WI, Park DW, Joh JH. 2019; Clinical features and management of “phlebitis-like abnormal reaction” after cyanoacrylate closure for the treatment of incompetent saphenous veins. Ann Vasc Surg. 55:239–45. DOI:
10.1016/j.avsg.2018.07.040. PMID:
30217712.
Article
16. Gibson K, Minjarez R, Rinehardt E, Ferris B. 2020; Frequency and severity of hypersensitivity reactions in patients after VenaSealTM cyanoacrylate treatment of superficial venous insufficiency. Phlebology. 35:337–44. DOI:
10.1177/0268355519878618. PMID:
31554473.
Article